Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with DMAC: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
DMAC
DiaMedica Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
DMAC
DiaMedica Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
DMAC
Uncorrelated: r 0.16 · 499D.
No shared co-movers.
LLY, solid
DMAC, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,423.39
▲
+0.38%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
DMAC
DiaMedica Therapeutics Inc.
Change
10.23
▼
−4.98%
Regular session
Nov 5 '26
Mkt cap
$580.8M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
DMAC
DiaMedica Therapeutics Inc.
1,423.39
▲
+0.38%
Price
10.23
▼
−4.98%
$1.3T
Mkt cap
$580.8M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,423.39
▲
+0.38%
vs
DMAC
10.23
▼
−4.98%
Regular session
Nov 5 '26